Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFCILLIN for Endocarditis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 16 adverse event reports in the FDA FAERS database where NAFCILLIN was used for Endocarditis.

Most Reported Side Effects for NAFCILLIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 38 17.7% 11 21
Acute kidney injury 18 8.4% 0 11
Nephropathy toxic 17 7.9% 0 1
Drug hypersensitivity 12 5.6% 0 2
Drug reaction with eosinophilia and systemic symptoms 11 5.1% 2 6
Rash 11 5.1% 0 5
Drug interaction 10 4.7% 3 7
Diarrhoea 9 4.2% 0 8
Hepatotoxicity 9 4.2% 1 0
Neutropenia 9 4.2% 0 4
Pruritus 9 4.2% 0 4
Pyrexia 9 4.2% 0 7
Treatment failure 9 4.2% 1 7
Hypokalaemia 7 3.3% 0 4
Tubulointerstitial nephritis 7 3.3% 0 4

Other Indications for NAFCILLIN

Staphylococcal infection (35) Product used for unknown indication (30) Staphylococcal bacteraemia (25) Bacterial infection (17) Antibiotic therapy (13) Osteomyelitis (10) Staphylococcal sepsis (10) Bacteraemia (6) Device related infection (6) Endocarditis staphylococcal (6)

Other Drugs Used for Endocarditis

VANCOMYCIN (733) DAPTOMYCIN (506) GENTAMICIN (425) RIFAMPIN (296) AMOXICILLIN (279) CEFTRIAXONE (254) LINEZOLID (186) LEVOFLOXACIN (86) CEFAZOLIN (77) MEROPENEM (75)

Related Pages

NAFCILLIN Full Profile All Endocarditis Drugs NAFCILLIN Demographics NAFCILLIN Timeline